High Court To Hear Merck Bid In Vioxx Class Action

Law360, New York (May 26, 2009, 12:00 AM EDT) -- In the latest twist in the long-running saga over Merck & Co.'s recalled painkiller Vioxx, the U.S. Supreme Court has agreed to consider the pharmaceutical giant's appeal of a lower court ruling that reinstated a securities class action alleging Merck covered up the health risks of the drug.

In a short order issued Tuesday, the Supreme Court granted Merck's petition for a writ of certiorari to reconsider an appeals court's ruling to reinstate the suit, which the drug company has argued should be dismissed because investors...
To view the full article, register now.